Taskforce T3 (Test, Trace, Treat) began in April 2020 as the private sector-led initiative to support the government in its efforts to combat COVID-19. T3 has been working closely with the national government since the beginning of its COVID-19 response, from the provision of PPE, medical supplies, increasing testing capacity, healthcare worker hiring, to the implementation of the National Vaccine Roadmap.

Charts

T3 Workstreams

Laboratory & Testing

T3 and its partners were pivotal in the expansion of PCR labs across the country. By the end of December 2020 almost 7 million tests were conducted

Data & Analytics

T3 supported the creation of a dashboard for NTF. The dashboard was used by the national government in daily NTF calls and helped in the conduct of interventions impact analysis, wherein testing was plotted with cases and quarantine statuses.

One Hospital Command

T3 Partners developed the first version of the One Hospital Command Center (OHCC) unified call taking algorithm, which was the core guiding document to the activities of the OHCC and how it links with the DOH1555. Additional partners such as FPH-iCONN were onboard to serve as the call overflow that allowed them to accommodate surges in calls and alleviate the load on the OHCC.

Technical support in Vaccine Service Continuity Planning

Institutionalized as a technical working group under the National Vaccine Operations Center, the service continuity team ensures the continued essential service of vaccine administration. The team has assisted NVOC by conducting table top exercises as well as review of incident reports concerning the vaccines.

Healthcare worker hiring support

T3 linked LGU’s to organizations such as BPOs to augment their healthcare worker needs in NCR and other regions. The team has also worked on policies which support the call for other medical professionals to be considered as vaccinators.

Demand generation for special populations

T3 has worked with the DOH and other stakeholder groups in creating accessible materials to special populations. These include the: